Mine Miskioğlu

Mine Miskioğlu

Auto-generated profile, based on publicly available information

Mine Miskioğlu

MANİSA CELÂL BAYAR ÜNİVERSİTESİ, TIP FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2020 in Turkish Journal of Hematology
Verified
Journal Article
Open access
MŞMustafa Şahin
Mustafa Şahin
MMMine Miskioglu
Mine Miskioglu
IIIşıl Inanır
Işıl Inanır
HAHikmet Akar
Hikmet Akar
NNNalan Neşe
Nalan Neşe
İAİsmet Aydoğdu
İsmet Aydoğdu

1 January 2024 in OSMANGAZİ JOURNAL OF MEDICINE
Verified
Journal Article
Closed access
MŞMustafa Şahin
Mustafa Şahin
BÖBatuhan Özbaş
Batuhan Özbaş
AKAyşe Kaya
Ayşe Kaya
MMMine Miskioğlu
Mine Miskioğlu
ÖBÖzgür Bayturan
Özgür Bayturan
İAİsmet Aydoğdu
İsmet Aydoğdu
Cytosine Arabinoside (Cytarabine) is commonly used agents in acute myeloid leukemia (AML). Cardiovascular side effects are not common during treatment. We aimed to present asymptomatic bradycardia developed during the first consolidation treatment in a patient with acute myeloid leukemia. A 34-year-old male patient was diagnosed with AML in February. After induction chemotherapy, high dose cytarabine treatment was started at 2x1.5 grams/m² for consolidation treatment. On the 11th day of the treatment, his pulse decreased to 39 beats/min. On the 12th day after the initiation of high dose cytosine arabinoside treatment (6 days after chemotherapy treatment ends), the patient's pulse rate was above 50/min, and there was no bradycardia in the following days. Other causes of other causes of bradycardia were excluded. It was reported that the patient had sinus bradycardia with an ejection fraction of 65% and his heart rate was rhythmic. There are seven patients with acute myeloid leukemia, one patient with acute lymphoblastic leukemia, one patient with non-Hodgkin's lymphoma, and one patient with Hodgkin's lymphoma who reported high dose cytosine arabinoside associated bradycardia. In addition, one patient with acute myeloid leukemia developed bradycardia with low dose cytosine arabinoside. Our case is the 11th case in the literature that develops bradycardia due to cytarabine.

26 March 2025 in Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi
Verified
Journal Article
Open access
PDF file
SGSümeyye Gökduman
Sümeyye Gökduman
NONilufer Ozdemir
Nilufer Ozdemir
MMMine Miskioğlu
Mine Miskioğlu
CACan Akçura
Can Akçura
BSBERNA BILGIN SAHIN
BERNA BILGIN SAHIN
ZHZeliha Hekimsoy
Zeliha Hekimsoy
Objective: Thyroid stimulating immunoglobulin (TSI) is used in the differential diagnosis of thyrotoxicosis and disease recurrence and activity. However, the accessibility and the cost can limit the use of TSI. In our study, we investigated the existence of easily accessible markers that can be used instead of TSI in the diagnosis and follow-up of Graves' disease (GD). The aim was to evaluate the relationship between TSI levels and inflammatory markers such as neutrophil-lymphocyte ratio (NLR), monocyte-lymphocyte ratio (MLR), platelet-lymphocyte ratio (TLR), systemic immune inflammation (SII) index, pan-immune inflammation value (PIV) obtained from the complete blood count of the patients at the beginning and 6 months after anti-thyroid treatment. Materials and Methods: 162 patients diagnosed with Graves' disease were retrospectively investigated. According to the free T4 level, the patients were divided into 3 groups as mild, moderate, and severe disease. Thyroid function tests, hemogram parameters, and TSI values of the patients at the time of diagnosis and after 6 months of anti-thyroid treatment were compared. The correlation of the statistically significant parameters with TSI was studied separately for each group. Results: While there was a significant increase in hemoglobin (p=0.009), leukocyte (p=0.001), neutrophil (p=0.002), lymphocyte (p=0.002), eosinophil (p=0.033), basophil (p=0.001) and TSH (p=0.001) levels after treatment compared to the baseline, there was a significant decrease in monocyte (p=0.003), platelet (p=0.010), TLR (p=0.001), MLR (p=0.001), freeT3 (p=0.001), freeT4 (p=0.001) levels. The correlation of these statistically significant parameters with TSI was observed. When the baseline and 6th month post-treatment values were investigated in all patients; a weak positive correlation was detected between TSI and monocytes and MLR, and a weak positive correlation was detected with freeT3. A weak positive correlation was detected between TSI and RDW and freeT3 in the severe disease group. Conclusion: Although a reliable marker that can be used as an alternative to TSI in the follow-up of Graves' disease has not been available, monocyte level, MLR and RDW in patients with severe Graves’ disease may predict an activation in the follow-up of the disease.

9 September 2024 in Ege Tıp Dergisi
Verified
Journal Article
Open access
PDF file
MŞMustafa Şahin
Mustafa Şahin
UKUğur Kamiloğlu
Uğur Kamiloğlu
AKAyşe Kaya
Ayşe Kaya
MMMine Miskioğlu
Mine Miskioğlu
GEGörkem Eskiizmir
Görkem Eskiizmir
İAİsmet Aydoğdu
İsmet Aydoğdu
Hodgkin lymphoma is lymphoid neoplasm in which the malignant cells admixed with a heterogeneous population of non-neoplastic inflammatory cells. A combination of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) is the most commonly used chemotherapy regime for Hodgkin lymphoma. In this case report, we present a patient with Hodgkin lymphoma who developed bilateral auricular hematoma after a first time administrition of ABVD treatment. A 27-year-old female patient was presented to the hematology outpatient clinic with a swelling in the neck for two weeks. An excisional biopsy performed from the left axillary region. The pathology report demonstrated classical Hodgkin lymphoma was noticed to be consistent with mixed cellular type. First dose ABVD protocol was administered to the patient. One week after chemotherapy, swelling and discoloration were observed in the patient's bilateral auricles without a history of trauma. The patient was consulted to the Department of Otorhinolarngology-Head and Neck Surgery. Bilateral drainage of auricular hematoma was performed immediately. Intravenous ciprofloxacin was also administered. The auricular hematoma did not reoccur after the subsequent chemotherapy treatments.